Electrolyte Imbalance Analysis at Intensive Care Unit Admission : Retrospective Study

Sponsor

Kecioren Education and Training Hospital (Other)

Overall Status

Completed

CT.gov ID

NCT05052463

Collaborator

(none)

824

Enrollment

Location

20.2

Actual Duration (Months)

40.8

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The type and severity of electrolyte imbalance in patients admitted to the intensive care unit were analyzed.It was evaluated whether these results had an effect on mortality, length of hospital stay, APACHE II scores and ventilator days

Condition or Disease	Intervention/Treatment	Phase
Electrolyte Imbalance	Other: electrolyte imbalance analysis

Study Design

Study Type:

Observational

Actual Enrollment :

824 participants

Observational Model:

Cohort

Time Perspective:

Retrospective

Official Title:

Electrolyte Imbalance Analysis at Icu Admission : Retrospective Study

Actual Study Start Date :

Dec 10, 2019

Actual Primary Completion Date :

Apr 5, 2021

Actual Study Completion Date :

Aug 15, 2021

Arms and Interventions

Arm	Intervention/Treatment
sodium (hypo-hyper-normonatremia)	Other: electrolyte imbalance analysis ın this retrospective study we aimed to evaluate the relationship between the ıcu prognosis and the electrolyte imbalance
potassium (hypo-hyper-normokalemia)	Other: electrolyte imbalance analysis ın this retrospective study we aimed to evaluate the relationship between the ıcu prognosis and the electrolyte imbalance
calcium (hyper-hypo-normocalcemia)	Other: electrolyte imbalance analysis ın this retrospective study we aimed to evaluate the relationship between the ıcu prognosis and the electrolyte imbalance
magnesium (hyper-hypo-normocalcemia)	Other: electrolyte imbalance analysis ın this retrospective study we aimed to evaluate the relationship between the ıcu prognosis and the electrolyte imbalance
phosphor (hypo-hyper-normophosphatemia)	Other: electrolyte imbalance analysis ın this retrospective study we aimed to evaluate the relationship between the ıcu prognosis and the electrolyte imbalance

Outcome Measures

Primary Outcome Measures

The analysis the electrolyte imbalance in ICU and the relationship between the icu prognosis. [2 years]
Natremia (Hypo: <136 mmol/L, Normo: 136-145 mmol/L, Hyper: >145 mmol/L) Kalemia (Hypo: <3.5 mmol/L, Normo: 3.5-5.5 mmol/L, Hyper: >5.5 mmol/L) Calcemia (Hypo: <8.8 mg/dL, Normo: 8.8-10.6 mg/dL, Hyper: >10.6 mg/dL) Magnesemia (Hypo: <1.9 mg/dL, Normo: 1.9-2.5 mg/dL, Hyper: >2.5 mg/dL) Phosphatemia (Hypo: <2.5 mg/dL, Normo: 2.5-4.5 mg/dL, Hyper: >4.5 mg/dL) The number of patients in all types of electrolyte imbalance will be determined. The effect of the type of electrolyte imbalance on mortality, APACHE-II score and length of invasive ventilation and hospital stay will be evaluated.

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria: all of the ıcu patients -

Exclusion Criteria:

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Ankara Kecioren Training and Research Hospital	Ankara	Çankaya	Turkey

Sponsors and Collaborators

Kecioren Education and Training Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

ESRA OZAYAR, Head of Anesthesiology and Reanimation Department, Kecioren Education and Training Hospital

ClinicalTrials.gov Identifier:

NCT05052463

Other Study ID Numbers:

erbil elektrolit

First Posted:

Sep 22, 2021

Last Update Posted:

Sep 28, 2021

Last Verified:

Sep 1, 2021

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Study Results

No Results Posted as of Sep 28, 2021